Skip to content

Author

K. Jardemark

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

434. The effect of kynurenic acid (KYNA) release on glutamatergic transmission in the hippocampus - a model of schizophrenia

Abstract Background Schizophrenia is a psychiatric disorder that has debilitating symptomatic manifestations, including psychotic episodes, depression-like symptoms, as well as cognitive dysfunction, all three of which contribute to the heavy disease burden for the individual. Multiple hypotheses have been developed in...

K. Jardemark, G. Engberg, K. Lindelöf et al. · 0 citations
Open access Sep 2026

437. Development of novel add-on treatment of cognitive dysfunction in schizophrenia

Preliminary data show that the butyryl cholinesterase inhibitor GUK1811 could modulate glutmatergic transmission in the hippocampus, and may, thus, have a potential to ameliorate cognitive dysfunction related to this brain region in schizophrenia.

K. Jardemark, J. Bruton, M. Shahid et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.